FindTrial
Sign In

Diagnostic ability of NaF bone PET/CT for detecting active arthritis in patients with rheumatoid arthritis

Clinical value of dual-phase F-18 NaF bone PET/CT in patients with rheumatoid arthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002597
Enrollment
60
Registered
2017-12-15
Start date
2017-12-29
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Catholic Kwandong University International St.Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Age of 18 years or more 2) Diagnosed as rheumatoid arthritis according to the 2010 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) classification criteria for rheumatoid arthritis 3) Had two or more sites of active arthritis on physical examination 4) DAS (disease activity score)28ESR =3.2

Exclusion criteria

Exclusion criteria: 1) Had a history of malignant disease within 5 years 2) Had a history of metabolic bone disease 3) Cannot perform F-18 NaF bone PET/CT because of pregnancy or pathologic condition such as claustrophobia 4) Age of less than 18 years

Design outcomes

Primary

MeasureTime frame
Diagnostic ability for detecting active arthritis and comparison with diagnostic ability of bone scintigraphy using Tc-99m diphosphonate—

Secondary

MeasureTime frame
Serum inflammatory markers—

Countries

Korea, Republic of

Contacts

Public ContactJeong Lee

Catholic Kwandong University International St.Mary's Hospital

sads00@naver.com+82-32-290-2975

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 16, 2026